Severe Cutaneous Adverse Drug Reaction
Background: Cutaneous adverse drug eruption (CADR) are frequently found. A systematic review showed, the incidence of severe CADR (SCADR) ranging from 0-8%. Few studies have assessed the severe form of CADR, which has high mortality rate. The epidemiological study was needed to show the profile of S...
Saved in:
Main Authors: | Damayanti Damayanti (Author), Sylvia Anggraeni (Author), Cita Rosita SP (Author), Marsudi Hutomo (Author), Hari Sukanto (Author) |
---|---|
Format: | Book |
Published: |
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicoepidemiological Profile of Severe Cutaneous Adverse Drug Reaction: A Retrospective Study
by: Damayanti Damayanti, et al.
Published: (2019) -
Skin Test for Cutaneous Adverse Drug Reactions
by: Yusuf Wibisono, et al.
Published: (2020) -
Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022) -
Recent advances in severe cutaneous adverse drug reaction
by: Sudip Das, et al.
Published: (2018) -
Cutaneous adverse drug reaction in Human Immunodeficiency virus patient associated with antiviral therapy: A retrospective study
by: Vidyani Adiningtyas, et al.
Published: (2019)